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Abstract
Antibiotic resistance in Streptococcus pneumoniae has increased worldwide by the spread of a few clones. Fluoroquinolone
resistance occurs mainly by alteration of their intracellular targets, the type II DNA topoisomerases, which is acquired either
by point mutation or by recombination. Increase in fluoroquinolone-resistance may depend on the balance between
antibiotic consumption and the cost that resistance imposes to bacterial fitness. In addition, pneumococcal prophages
could play an important role. Prophage induction by fluoroquinolones was confirmed in 4 clinical isolates by using Southern
blot hybridization. Clinical isolates (105 fluoroquinolone-resistant and 160 fluoroquinolone-susceptible) were tested for
lysogeny by using a PCR assay and functional prophage carriage was studied by mitomycin C induction. Fluoroquinolone-
resistant strains harbored fewer inducible prophages (17/43) than fluoroquinolone-susceptible strains (49/70) (P= 0.0018). In
addition, isolates of clones associated with fluoroquinolone resistance [CC156 (3/25); CC63 (2/20), and CC81 (1/19)], had
lower frequency of functional prophages than isolates of clones with low incidence of fluoroquinolone resistance [CC30 (4/
21), CC230 (5/20), CC62 (9/21), and CC180 (21/30)]. Likewise, persistent strains from patients with chronic respiratory
diseases subjected to fluoroquinolone treatment had a low frequency of inducible prophages (1/11). Development of
ciprofloxacin resistance was tested with two isogenic strains, one lysogenic and the other non-lysogenic: emergence of
resistance was only observed in the non-lysogenic strain. These results are compatible with the lysis of lysogenic isolates
receiving fluoroquinolones before the development of resistance and explain the inverse relation between presence of
inducible prophages and fluoroquinolone-resistance.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a major etiological
agent of community-acquired pneumonia, meningitis and acute
otitis media, as well as an important cause of acute exacerbations
in patients with chronic respiratory diseases [1]. Antimicrobial
resistance in the pneumococcus (including resistance to b-lactams,
macrolides, tetracycline and co-trimoxazole) has expanded world-
wide [2], influenced by patterns of antibiotic use and spread of a
few international clones [3]. Therefore, fluoroquinolones (Fqs) are
nowadays widely used for treating community-acquired pneumo-
nia and other respiratory diseases in adults [4]. In Spain, the
current prevalence of Fq resistance in pneumococci is lower than
3%, although it reaches 6.6% among strains isolated from acute
exacerbations of chronic obstructive pulmonary disease [5,6]. We
have found that CC156, CC63, and CC81 are the main FqR
clones since 2002 in Spain [5,7].
Resistance to Fqs in pneumococci occurs mainly by alteration of
their intracellular drug targets, i.e., DNA topoisomerase IV and
DNA gyrase. Fqs inhibit these enzymes by forming a ternary
complex of drug, enzyme, and DNA. Their killing effect has been
related to the resolution of reaction intermediates of DNA-Fq-
topoisomerase, which yield to the formation of irreparable double-
stranded DNA breaks [8]. However, it has been also described
that hydroxyl radical formation utilizing internal iron and the
Fenton reaction are generated following gyrase poisoning and play
an important role in cell killing by Fqs [9]. Fq resistance is
acquired by point mutation as well as by intraspecific or
interspecific recombination with streptococci of the mitis group
[10–12]. A future increase in Fq resistance in S. pneumoniae would
depend on the balance between antibiotic consumption and the
cost that resistance imposes to bacterial fitness. A direct
relationship between Fq consumption and increase in the
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e94358
prevalence of resistance in S. pneumoniae was reported [13]. We and
others have reported that specific Fq-resistant (FqR) mutations
confer a fitness cost to S. pneumoniae [14,15]. However, compen-
sation of this fitness cost in isolates carrying recombinant
topoisomerase genes has been observed [16]. In this context, if
Fqs are able to induce pneumococcal prophages, they might have
an important role in the emergence of Fq resistance in S.
pneumoniae and would also modulate bacterial fitness in the
presence of Fqs. Induction of prophages by Fqs has not been yet
investigated in S. pneumoniae. This process has been described,
among Gram-positive bacteria, only in Streptococcus canis [17],
Staphylococcus aureus [18,19], Enterococcus faecalis [20], and Clostridium
difficile [21]. Two methods have been used to estimate rates of
prophage carriage in S. pneumoniae, which reach different values: a)
42% was deduced from induction of bacterial lysis with mitomycin
C (MitC) [22], and b) 76% was proposed from hybridization with
a lytA bacterial probe [23]. Recently, using a PCR protocol,
pneumococcal prophages have been classified into three types
[24]. A study performed in 240 isolates of the CC81 clone showed
multiple recombination events at the prophage region [25],
suggesting that the presence of phages genes does not always
equate to the presence of a functional phage.
In this study we have performed experiments of phage induction
in the presence of Fqs and investigated the relation between
presence of inducible prophages and Fq resistance in clinical
isolates of S. pneumoniae.
Materials and Methods
Ethics statement
This study and publication of the results were approved by the
‘‘Comite´ E`tic d’Investigacio´ Clı´nica del Hospital Universitari de
Bellvitge’’ and the written or oral informed consent was considered
not necessary, because the source of bacterial isolates was
anonymized and the study was retrospective.
Bacterial isolates
FqR [ciprofloxacin (CPX) MICs$4 mg/L] strains were isolated
during the 2002–2009 period from 112 hospitals nationwide and
previously published [5,7]. A randomized selection of FqS isolates
collected at Bellvitge Hospital during the same period was used as
a control. Most isolates were from invasive sites (blood [90],
cerebrospinal fluid [9], pleural fluid [18], synovial fluid [2]), and
respiratory tract samples (sputum [125], bronchoalveolar lavage
[12]). Clonal complex (CC) characterization was made on the
basis of pulsed-field gel electrophoresis (PFGE) and assessed by
multilocus sequence typing (MLST). Briefly, genomic DNA
embedded in agarose plugs was restricted with SmaI or ApaI
and fragments were separated by PFGE in a CHEF-DRIII
apparatus (Bio-Rad). PFGE patterns were compared with
representative clones of the Pneumococcal Molecular Epidemiol-
ogy Network (PMEN), the world-wide epidemic clones [3]. Isolates
with patterns varying by three or less bands were considered to
represent the same PFGE type. In order to assess the identity with
global pneumococcal clones, at least one isolate of each PFGE
pattern/serotype combination was analyzed by MLST. Allele
numbers and sequence types (ST) were assigned using the MLST
web site (http://www.mlst.net).
Detection of phage DNA
PCR detection of the hol1 gene, indicative of the presence of
phage, was performed as described previously [24]. Strains with
hol1 positive PCR were tested for the presence of int1, int2 and mtp
with specific oligonucleotide pairs to identify phage types.
Fragments of parC or rpoB genes, which were amplified with
oligonucleotides parC50/parC152, or rpoB428/rpoB474R [14],
respectively, were used as controls. Strains 949, which carry the
type 1 prophage MM1, and R6 (no prophage), were used as
controls. For phage induction, cultures were grown exponentially
in Todd-Hewitt medium supplemented with 0.5% of yeast extract
(THY) at 37uC until OD620 = 0.1. Then, growth kinetics of isolates
with and without the addition of 75 ng/mL MitC was monitored
by OD620 measured every 15 min during a 4-h period. The
induction with MitC was considered positive when a 2-to 3-fold
decrease in OD with respect to the untreated culture was observed
after 2-to 3 h of treatment.
Southern blot hybridizations
Cultures were grown exponentially until OD620 = 0.1. At this
time (time 0) antibiotics were added at concentrations equivalent
to 16MIC for each strain and samples were taken during 4 h.
Phage and chromosomal DNAs were obtained as follows. First,
2.92 g of NaCl were added to 50 mL of culture, and the solution
kept at 4uC for 1 h. The suspension was centrifuged at 2,2006g for
20 min at 4uC. The supernatant, containing phages, was
precipitated overnight at 4uC with polyethylene glycol 800 (1 g/
10 mL solution). The suspension was centrifuged at 11,2006g
during 15 min at 4uC and the pellet suspended in 0.5 mL of buffer
(100 mM Tris-HCl pH 7.5, 0.1 M NaCl, 10 mM MgCl2). To
eliminate cellular nucleic acids, the phage suspension was treated
with RNase and DNase (100 mg/mL each) during 1 h at 37uC.
Phage particles were digested 90 min with proteinase K (150 mg/
mL) in the presence of 0.5% SDS and 50 mM EDTA at 50uC.
Phenol extraction and ethanol precipitation allowed the isolation
of phage DNA. A 191-bp phage probe containing hol1 was
obtained with biotinylated P9 and P9-R oligonucleotides [24]
using strain 949 as template. The Phototope-Star Detection Kit
(New England Biolabs) was used following the manufacturer’s
instructions.
Statistical analysis
The Fisher exact test (x2 test) was used when appropriate.
P,0.05 was considered significant.
Results
Induction of prophages by Fq treatment
First, the kinetics of growth of two isolates, (CipR-6.55 and
CipR-6.49) belonging to the CC156 clone was analyzed in the
presence of Fqs and MitC, a typical prophage inducer. Treatment
with CPX and levofloxacin (LVX) inhibited the growth of both
isolates in a concentration-dependent manner, being the inhibition
more evident in CipR-6.55 (carrying phages of types 1 and 2) than
in CipR-6.49 (no prophages), which suggested prophage induction
by the drug. In accordance, CipR-6.55 showed lysis after
treatment with MitC (Figure 1). This lysis was also observed in
three additional isolates, one of CC156 (CipR-6.87, with two
phages of types 1 and 2), and two of CC63 with phages of type 2
(CipS-6.3 and CipS-6.10). Phage induction was also followed by
Southern blotting. First, phage induction was tested in CipR-6.55
in the presence of CPX and LVX, MitC and the gyrase B inhibitor
novobiocin. Phage DNA was purified, digested with EcoRV and
hybridized with a hol1 probe. As shown in Figure 2, discrete
restriction bands were detected in the culture supernatants, which
corresponded to phage DNA. Some basal spontaneous induction
of phage was also observed in the untreated cultures. However, the
amount of phage DNA, as detected by hybridization, was higher
when Fqs or MitC were used. These results showed induction of
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prophages by both Fqs and MitC, but not by novobiocin. Given
that induction by LVX was more efficient than by CPX, the first
Fq was chosen for further studies. In three additional lysogenic
isolates studied, induction with LVX and MitC was also observed
(Figure 2).
Detection of prophages by PCR in a collection of
S. pneumoniae isolates
A total of 265 clinical isolates were tested for the presence of
phages [105 FqR and 160 Fq-susceptible (FqS)]. Of them, 113
(42.6%) carried prophage DNA, and no significant difference was
found among FqR (40.9%; 43/105) and FqS (43.5%; 70/160).
Likewise, no difference was observed among prophage carriage
rates of isolates collected from invasive samples (36.9%; 45/122)
and respiratory tract samples (46.7%; 64/137). Types 1 and 2
prophages were more abundant than those of type 3. A majority
(77/113) of isolates carried prophages of a single type, (51 isolates
with type 1 phages, 25 isolates with type 2 phages and 1 isolate
with a type 3 phage), 16 isolates carried prophages of two types (11
isolates with types 1 and 2, and 5 isolates with types 2 and 3), and 6
isolates carried prophages of the three types. Fourteen isolates
showed amplification with hol1 oligonucleotides but not with those
specific for int1, int2 or mtp suggesting the presence of prophage
remnants or of temperate phages of an unknown type.
Presence of inducible prophages among isolates of
prevalent clones
Since we showed a correlation between prophage induction by
MitC and Fqs (Figures 1 and 2), MitC induction was chosen to test
the functionality of the prophages detected by PCR in all lysogenic
isolates. The kinetics of growth in the presence of MitC was
analyzed as described in methods. Among 113 lysogenic isolates,
only 66 (58.4%) exhibited detectable lysis after treatment with
MitC. The frequencies of functional prophages were statistically
lower (P = 0.0018) in FqR (17/43) than in FqS (49/70) isolates
(Table 1). No difference was observed in the distribution of
functional phages among invasive (28/122) and respiratory tract
samples (37/137).
As shown in Table 1, several clones had low presence of phage
DNA: CC156; CC81; CC63; and CC306. No association between
the type of phage carried and the genotype was observed. Isolates
of the same clone carried different phage types or combinations,
with the exception of CC180 in which 20 out of 22 isolates carried
a type 1 prophage. Four clones: CCT156 (3/25); CC63 (2/20);
Figure 1. Lysogenic isolates exhibited lysis in the presence of mitomycin C and fluoroquinolones. The growth kinetics of three isolates
of the CC156 clone (one non-lysogen and two lysogens) and two lysogenic isolates of the CC63 clone were followed in the presence of
fluoroquinolones or MitC. Cultures growing exponentially in THY at 37uC to OD620 = 0.1 were divided and treated as indicated. Growth was monitored
every 15 min during a 4-h period.
doi:10.1371/journal.pone.0094358.g001
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CCT81 (1/19) and CC306 (1/29) showed low rates of functional
prophage carriage. The first three are the main FqR Spanish
clones since 2002 [5,7] whereas, CC306, is usually antimicrobial
susceptible. On the other hand, isolates belonging to CC180 (21/
30); CC30 (4/21); CC230 (5/20); and CC62 (9/21) showed higher
frequencies of functional prophage carriage. These last four clones
were low prevalent among FqR Spanish pneumococci [5,7].
Low frequency of inducible prophages among persistent
strains isolated from patients that received Fq treatment
To test the role of Fq therapy in phage induction in vivo, 11
persistent pneumococci collected from 10 adult patients with
chronic respiratory diseases were studied (Table 2). Details of these
strains have been previously reported [26]. All isolates from each
patient were clonally related (same MLST) and were repeatedly
isolated throughout the period (27 to 165 weeks) in which these
patients received multiple Fq therapy courses. Only isolates of two
patients (7 and 11) showed a positive detection of the hol1 gene.
Moreover, only prophages from the pneumococci of patient 7
were induced with MitC. Four strains were FqR since the first
isolation and did not carry any inducible prophages, although one
of them had a phage remnant (patient 11). Among the five FqS
strains that did not carry prophages, two developed resistance after
Fq course (patients 7 and 9). Patient 7 was sequentially colonized
Figure 2. Prophage induction with Fqs and mitomycin C was detected by Southern-blot hybridization. Cultures were grown either
without treatment (C), or in the presence of antibiotics at concentrations equivalent to 16MIC: 32 mg/ml of ciprofloxacin (CPX); 1–16 mg/ml of
levofloxacin (LVX); 1 mg/ml of novobiocin (NOV). MitC was used at 75 ng/ml. Phages were concentrated from the supernatant as described in
methods at the beginning of the experiment (time 0) and at 1-to 4 h after treatment. (A, C, E. and G) Amounts of DNA equivalent to 0.5 OD620 units of
the culture were digested with EcoRV, run in 0.8% agarose gels, and stained with ethidium bromide. (B, D, F and H) The DNA bands were blotted to a
nylon membrane and hybridized with a hol1-probe.
doi:10.1371/journal.pone.0094358.g002
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Table 1. Relevant characteristics of S. pneumoniae isolates and their prophages analyzed in this study.
Type of phage
CCa (no. of isolates) Phenotypeb hol1 +c MitC +d 1 2 3 1+2 1+2+3 2+3 Other
CC180 (30) 29 S 22 21 20 2 2 2 2 2 2
1 R 0 0 2 2 2 2 2 2 2
CC306 (29) 28 S 1 1 2 2 2 2 2 2 1
1 R 0 0 2 2 2 2 2 2 2
CC156 (25) 6 S 1 1 2 1 2 2 2 2 2
19 R 3 2 2 1 2 2 2 2 2
CC30 (21) 17 S 8 4 2 2 2 2 2 2 4
4 R 1 0 2 2 2 2 1 2 2
CC62 (21) 19 S 14 8 6 4 2 2 2 2
2 R 2 1 2 2 2 2 2 2 2
CC63 (20) 7 S 2 2 2 2 2 2 2 2 2
13 R 1 0 2 2 2 2 2 2 1
CC230 (20) 18 S 6 4 1 3 2 2 2 2 2
2 R 1 1 1 2 2 2 2 2 2
CC81 (19) 7 S 2 0 2 2 2 2 2 2 2
12 R 4 1 2 3 2 2 2 2 1
CC97 (6) 3 S 3 1 3 2 2 2 2 2 2
3 R 3 0 2 2 2 2 2 2 1
CC433 (6) 3 S 1 1 1 2 2 2 2 2 2
3 R 2 0 1 2 2 1 2 2 2
CC42 (5) 4 S 0 0 2 2 2 2 2 2 2
1 R 0 0 2 2 2 2 2 2 2
CC717 (5) 3 S 3 1 3 2 2 2 2 2 2
2 R 2 2 2 2 2 2 2 2 2
CC17 (4) 2 S 2 2 2 2 2 2 2 2 2
2 R 2 1 2 2 2 2 2 2 2
CC90 (4) 2 S 2 1 2 1 2 2 1 2 2
2 R 2 1 2 1 2 2 1 2 2
CC260 (4) 2 S 0 0 2 2 2 2 2 2 2
2 R 1 0 1 2 2 2 2 2 2
CC67 (3) 2 S 2 2 2 2 2 2 2 2 2
1 R 0 0 2 2 2 2 2 2 2
CC191(3) 2 S 0 0 2 2 2 2 2 2 2
1 R 0 0 2 2 2 2 2 2 2
CC88 (2) 2 S 0 0 2 2 2 2 2 2 2
0 R 0 0 2 2 2 2 2 2 2
CC247 (2) 2 S 0 0 2 2 2 2 2 2 2
0 R 0 0 2 2 2 2 2 2 2
CC989 (2) 1 S 0 0 2 2 2 2 2 2 2
1 R 0 0 2 2 2 2 2 2 2
Others (34) 1 S 1 0 2 1 2 2 2 2 2
33 R 19 8 4 3 1 3 2 3 5
aClones are named by their clonal complex number. Those showed in boldface and underlined are the main clones involved in Fq resistance in Spain since 2002.
bIsolates are separated on the basis of their Fq susceptibility: S, susceptible (CPX MICs #2 mg/L); R, resistant (MICs $4 mg/L).
cPCR detection for hol1 gene.
dFunctional phages caused cell lysis in the presence of MitC.
doi:10.1371/journal.pone.0094358.t001
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by two different strains. Although the first one (of ST6315A) carried
functional prophage and developed Fq resistance, it was replaced
by a new nonlysogenic strain (ST55835B) after Fq therapy [26].
The presence of a prophage affects development of CPX
resistance
The observation that FqR isolates have lower rates of inducible
prophages than FqS pneumococci, together with the results of
induction of phages by Fqs, suggest that under Fq selective
pressure, lysogenic pneumococci will be prone to die due to phage-
mediated lysis, while non-lysogenic isolates would be able to
develop Fq resistance. Resistance would be hence more likely to
arise in isolates that do not carry prophage. To test this hypothesis,
two isogenic strains, R36A (wild type) and R36AP (an R36A
derivative carrying an inducible prophage) [27] were cultured for
4 h in the presence of 16MIC of CPX (0.5 mg/ml) and the
presence of quinolone resistant mutants was evaluated by plating
on several CPX concentrations (Figure 3). We assumed that
phage-mediated lysis would occur preferentially in liquid medium;
although we cannot discard that lysis is also occurring on plates. At
46MIC of CPX (2 mg/ml), there were no colonies in the R36AP
strain, while a total of 1.4610360.26103 (mean 6 SD) colonies
(frequency of 3.561025) were obtained from the R36A strain.
Among them, 8 isolates were selected and their parC QRDR
regions were sequenced as described [5,7]. Results showed that a
majority (6 out of 8) carry the S79Y mutation, a classical mutation
known to be involved in CPX resistance. At 3 mg/ml CPX, 2
colonies of the R36A strain were obtained (frequency of 561029),
one of these also carried the ParC S79Y change. These results are
consistent with a deleterious effect of prophage carriage for the
development of quinolone resistance in pneumococci.
Discussion
In this study we first showed that Fqs targeting topoisomerase
IV, such as CPX and LVX, are able to induce the lytic cycle of
pneumococcal temperate phages. Comparison of growth kinetics
in the presence of 16MIC of these fluoroquinolones showed lower
OD increases in isolates carrying inducible prophages, than in the
non-lysogenic CipR-6.49 isolate. This behavior was related with
the induction of cell lysis by the prophages. In contrast,
novobiocin, an inhibitor of the DNA gyrase, was unable to induce
lysis of CipR-6.55. All these results suggest a role of the inhibition
of topoisomerase IV in the lysis response. This could be a
consequence of the cellular processes acting on the ternary
complex formed by topoisomerase IV-Fq and DNA [8]. However,
it could also be due to transcriptional regulation of phage or
bacterial genes by changes in DNA supercoiling caused by
inhibition of topoisomerase IV, given that treatment of S.
pneumoniae with LVX causes a complex transcriptomic response
[28]. On this respect, it has been shown that the transcription of
the pneumococcal recA gene, a competence-induced gene, is
necessary for temperate phage induction [29], and that compe-
tence in S. pneumoniae, a bacterium lacking an SOS-like system, is
induced by Fqs and MitC but not by other antibiotics [30].
Since our results showed that Fqs caused bacterial lysis by phage
induction, we determined the rates of inducible phages in isolates
of the most frequent clones causing pneumococcal diseases in adult
patients. Using a PCR approach, we determined that about half of
the isolates analyzed were lysogenic, a figure compatible with the
previously reported value (42%) based on MitC induced bacterial
lysis [22], but lower than the 76% estimated by detection of the
prophage lytA-like gene by hybridization with a host lytA probe
[23]. However, both the PCR detection and the hybridization
approaches overestimate the rate of inducible, functional prophage
carriage, since these methods detect also defective prophages, and
experiments of induction with MitC were necessary to determine
the functional phage rate.
We showed that FqR isolates have lower rates of inducible
prophage carriage than FqS pneumococci. These findings,
Table 2. Persistent S. pneumoniae strains causing $3
episodes of acute exacerbations in patients with chronic
respiratory diseases.
Patient ID Clone Episode Fq phenotypea hol1/MitC b
1 ST1569V 1st to 3rd LL-R 2
3 ST8389V 1st to 4rd S 2
4 ST8389V 1st to 3rd HL-R 2
5 ST8389V 1st HL-R 2
2nd LL-R 2
3rd HL-R 2
7 ST6315A 1st, 2nd S +/+
3rd, 4rd, 6th HL-R +/+
ST55835B 5rd, 7th, 8th S 2
8 ST6315A 1st S 2
2nd to 5th LL-R 2
9 ST8819F 1st S 2
2nd and 3rd HL-R 2
10 ST8719F 1st to 5th S 2
11 ST210019F 1st to 3rd HL-R +/2
12 ST27619A 1st to 3rd S 2
aS, susceptible (CPX MICs#2 mg/L); LL-R, low- level of resistance (MICs 4–8 mg/
L); HL-R, high level of resistance (MICs $16 mg/L).
bhol1 + indicates PCR detection for hol1 gene; MitC + indicates cell lysis of the
culture in the presence of MitC.
doi:10.1371/journal.pone.0094358.t002
Figure 3. Non-lysogenic R36A strain developed CX-resistance
while lysogenic R36A (R36AP) did not. Overnight cultures of R36A
and R36AP were grown in THY until OD620 = 0.4, then these were
diluted 20-fold in 500 ml of the same medium and grown until
OD620 = 0.1. At this point CPX was added to the cultures to reach 16MIC
(0.5 mg/ml). Cultures were grown for 4 h and bacteria were recovered
by centrifugation at 5000 g for 30 minutes. Cells were suspended in
THY +25% glycerol at concentrations of 3.36108 and 4.16108 CFUs/ml
for R36A and R36AP, respectively. Bacteria were plated in THY agar
plates containing the indicated CPX concentrations. Results are the
means 6SD of three independent replicates.
doi:10.1371/journal.pone.0094358.g003
Induction of Prophages by Fluoroquinolones
PLOS ONE | www.plosone.org 6 April 2014 | Volume 9 | Issue 4 | e94358
together with the induction of phages by Fqs, and the inability to
select FqR isolates in the R36AP strain in conditions when these
arise readily in the non-lysogenic parental strain R36A, suggest
that under Fq pressure lysogenic pneumococci will be prone to die
due to phage-mediated lysis, while non-lysogenic isolates are able
to develop Fq resistance. Consistent with this hypothesis, isolates
belonging to the three main FqR Spanish clones (CC156, CC63,
and CC81), have a frequency of inducible prophages lower than
clones not related with Fq resistance, such as CC30, CC62 or
CC180. In contrast, the vast majority of isolates of CC306, which
were FqS, were non-lysogenic. There are two possible explanations
for this finding. The first is that isolates of this clone usually cause
invasive pneumococcal disease in children, who are not treated
with Fqs. The second is that, since this clone is rarely found as a
colonizer (neither in children nor adult patients with chronic
obstructive pulmonary disease), it may seldom exchange DNA
with other streptococci or have the chance to be infected by
temperate bacteriophages.
Another possibility could be that the clones within which Fq
resistance is most common are less likely to be lysogenic for
unrelated reasons. However, our results shown that there are
differences in the prevalence of inducible phage between different
clones not commonly resistant to Fq, ranging from 1/29 to 21/30
(Table 1) and experiments with isogenic strains differing only in
the carriage of a prophage support a role of prophages in
preventing the development of Fq resistance.
Finally, we found a low frequency of functional prophages
(1/11) in strains persistently colonizing patients which received
multiple courses of Fq therapy. These results also support the role
of prophage in cell lysis and development of in vivo Fq resistance in
S. pneumoniae. This ecological niche is optimal for the development
of antibiotic resistance; given that the patients had multiple
infections with different pathogens and that they received multiple
courses of antibiotic treatment. In relation with fluoroquinolone
treatments, the doses of CPX that are able to kill Gram-negative
bacteria are subinhibitory for S. pneumoniae and this would allow,
both the development of resistance in this kind of patients, and also
the induction of prophages.
The evolution of bacteria cannot be understood without the
contribution of their prophages [31]. These could change from
inducible to cryptic prophages (unable to excise from the
chromosome and cause cell lysis), which contribute significantly
to resistance to sub-lethal concentrations of Fqs and b-lactam
antibiotics primarily through phage-encoded proteins that inhibit
cell division, as recently demonstrated for Escherichia coli prophages
that do not excise on MitC treatment [32]. Lysogeny is also
important for interspecies competition, as showed by the killing of
S. aureus by prophage induction caused by H2O2 production by S.
pneumoniae in the nasopharynx [19]. Activation of key proteins
involved in phage-induced cell lysis, encoded either by the
prophages or by the bacterial host, may be a novel way to fight
antimicrobial resistance.
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